GPX4 is a protein associated with poor prognosis, potentially inhibiting ferroptosis in colon cancer cells through specific signaling pathways and interacting synergistically with HSPA5 (Yang et al., 2021; Wang et al., 2022). The gene discussed is HSPA5; the disease is malignant colon neoplasm.